Home » Topics » BioWorld

BioWorld
RSS

NIH TO GO PUBLIC WITH PATENT APPLICATION

Feb. 14, 1992

ERI ACQUIRES MICROBIOLOGICAL DEVELOPER

Feb. 13, 1992

GENETIC ENGINEERING ACQUIRED

Feb. 13, 1992

MEDICIS LICENSES HAIR LOSS DRUG

Feb. 13, 1992

IDEC TO CONSOLIDATE LOCATIONS

Feb. 13, 1992

GENZYME ANSWERS HIGH PRICE ALLEGATION

Feb. 13, 1992

TOP-TIER STOCKS SHAKEN IN FALLOUT

Feb. 13, 1992

CALGENE FILES FOR SECONDARY OFFERING

Feb. 12, 1992

COLLAGEN LIABILITY SUIT DISMISSED

Feb. 12, 1992

SERAGEN FILES FOR 3 MILLION-SHARE IPO

Feb. 12, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...